Inhibitors of cathepsin s

作者: Phillip B. Alper , Hong Liu , Donald S. Karanewsky

DOI:

关键词:

摘要: The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, S is selectively inhibited in presence at least one other isozyme. also treating disease state subject by inhibiting

参考文章(44)
Laurie H. Glimcher, John Douhan, Human c-Maf compositions and methods of use thereof ,(1999)
David Rasnick, Jeffrey Lee Klaus, James T. Palmer, Elaine Yee-Lin Kuo, Reversible cysteine protease inhibitors ,(1996)
Michael Graupe, John O. Link, Peptidic compounds as cysteine protease inhibitors ,(2003)
Sukanthini Thurairatnam, Michael Graupe, James T. Palmer, David J. Aldous, Novel compounds and compositions as cathepsin inhibitors ,(2002)
Renee Louise Desjarlais, Dennis Shinji Yamashita, Stacie Marie Halbert, Robert Wells Marquis, Baoguang Zhao, Yu Ru, Thomas Joseph Carr, Jack Hwekwo Yen, Scott Kevin Thompson, Daniel Frank Veber, Cheryl Ann Janson, Hye-Ja Oh, Sherin Salaheldin Abdel-Mequid, Thimothy Francis Gallagher, Ward Whitlock Smith, Method of inhibiting cathepsin k ,(1996)
Vidyasagar Vuligonda, Samuel J. Gillett, Tien T. Duong, Richard L. Beard, Min Teng, Roshantha A. Chandraratna, Alan T. Johnson, Acetylenes disubstituted with a 5 alkyl, aryl or heteroaryl substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity ,(1997)
Samuel R. Denmeade, John T. Isaacs, S. Brogger Christensen, Hans Lilja, Tissue specific prodrug ,(2000)